Testim
Please select a testosterone article from the list below:
- Market Wire - Paladin Reports Fourteenth Consecutive Year of Record Revenues
- Business Wire - Repros Reports Androxal® Restores Normal Sperm Counts While Increasing Testosterone Levels in Hypogonadal Men
- Market Wire - Data Presented at the 5th International AIDS Society Conference Suggests Low Testosterone Frequently Goes Undetected in HIV-Positive Men
- Market Wire - Paladin Reports Record 2008 Fourth Quarter and Year End Results
- Market Wire - Auxilium Pharmaceuticals, Inc. and CPEX Pharmaceuticals, Inc. File Lawsuit Against Upsher-Smith Laboratories, Inc. for Infringement of Testim(R) Patent
- Market Wire - Auxilium Pharmaceuticals, Inc. Announces Distribution and License Agreement for Testim(R) in Europe With Ferring Pharmaceuticals
- Market Wire - Auxilium Pharmaceuticals, Inc. and CPEX Pharmaceuticals, Inc. Receive Paragraph IV Certification Notice From Upsher-Smith Laboratories for Testim(R)
- Business Wire - Repros Therapeutics Inc. Initiates a Comparative Phase 2b Study of Oral Androxal® as Compared to Topical Testim® Examining Effects on Male Fertility and Testicular Function
- Daily Mail (London, England), The - Berties Alibi Is Blown Apart
- Market Wire - Paladin Reports Record 2007 Fourth Quarter and Year End Results
Thursday 25th of February 2010
Market Wire - Paladin Reports Fourteenth Consecutive Year of Record Revenues
Thursday 25th of February 2010, 3:59 pmFebruary 25, 2010 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, today reported its financial results for the fourth quarter and...
Wednesday 7th of October 2009
Business Wire - Repros Reports Androxal® Restores Normal Sperm Counts While Increasing Testosterone Levels in Hypogonadal Men
Wednesday 7th of October 2009, 4:59 pmOctober 7, 2009 -- HASH(0x2a966c01f0) THE WOODLANDS, Texas -- Repros Therapeutics Inc. (NasdaqGM:RPRX) today announced results from an exploratory,...
Tuesday 21st of July 2009
Market Wire - Data Presented at the 5th International AIDS Society Conference Suggests Low Testosterone Frequently Goes Undetected in HIV-Positive Men
Tuesday 21st of July 2009, 4:59 pmJuly 21, 2009 -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that new data from the two-part HYHYHI Study...
Thursday 26th of February 2009
Market Wire - Paladin Reports Record 2008 Fourth Quarter and Year End Results
Thursday 26th of February 2009, 3:59 pmFebruary 26, 2009 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, today reported its financial results for the fourth quarter and...
Thursday 4th of December 2008
Market Wire - Auxilium Pharmaceuticals, Inc. and CPEX Pharmaceuticals, Inc. File Lawsuit Against Upsher-Smith Laboratories, Inc. for Infringement of Testim(R) Patent
Thursday 4th of December 2008, 3:59 pmDecember 4, 2008 -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) and CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) announced today that they have filed a lawsuit against...
Monday 1st of December 2008
Market Wire - Auxilium Pharmaceuticals, Inc. Announces Distribution and License Agreement for Testim(R) in Europe With Ferring Pharmaceuticals
Monday 1st of December 2008, 3:59 pmDecember 1, 2008 -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) and Ferring International S.A. today announced an exclusive agreement between them for the European...
Friday 24th of October 2008
Market Wire - Auxilium Pharmaceuticals, Inc. and CPEX Pharmaceuticals, Inc. Receive Paragraph IV Certification Notice From Upsher-Smith Laboratories for Testim(R)
Friday 24th of October 2008, 4:59 pmOctober 24, 2008 -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) and CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) today announced that they have received a notice from...
Monday 30th of June 2008
Business Wire - Repros Therapeutics Inc. Initiates a Comparative Phase 2b Study of Oral Androxal® as Compared to Topical Testim® Examining Effects on Male Fertility and Testicular Function
Monday 30th of June 2008, 4:59 pmJune 30, 2008 -- Provides Guidance on Proellex Endometriosis Phase 2 Data and Initiation of Androxal Phase 2b Study for the Treatment of Hyperglycemia Provides...
Friday 21st of March 2008
Daily Mail (London, England), The - Berties Alibi Is Blown Apart
Friday 21st of March 2008, 12:00 amMarch 21, 2008 --
ON A dramatic and damagingdayfor theTaoiseach,his former secretary admittedshe had lodged sterling in Mr Aherns building society...
Thursday 28th of February 2008
Market Wire - Paladin Reports Record 2007 Fourth Quarter and Year End Results
Thursday 28th of February 2008, 3:59 pmFebruary 28, 2008 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, today reported its financial results for the fourth quarter and...